BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34496775)

  • 21. Survival nomogram for patients with initially diagnosed metastatic non-small-cell lung cancer: a SEER-based study.
    Wang Y; Pang Z; Chen X; Bie F; Wang Y; Wang G; Liu Q; Du J
    Future Oncol; 2019 Oct; 15(29):3395-3409. PubMed ID: 31512954
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer.
    Abdel-Rahman O
    Future Oncol; 2017 Oct; 13(25):2277-2284. PubMed ID: 28976218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 25. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
    Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
    Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
    Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
    Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
    Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
    Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
    BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
    Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.
    Abdel-Rahman O
    Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
    Shirvani SM; Jiang J; Chang JY; Welsh JW; Gomez DR; Swisher S; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1060-70. PubMed ID: 22975611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.